Personal Genomics: What’s Next?
Precision medicine and personal health require deep knowledge about the body – and each person’s biological characteristics. With her company 23andMe, Anne Wojcicki has pioneered the field of personal genomics, offering consumers an affordable way to have their DNA analyzed.
Over 80 percent of 23andMe’s ten million customers opt in to making their personal information available to research, Wojcicki told interviewer Kara Swisher, enabling the company “to crowdsource this incredible community of genetic information, and we use that to make discoveries”. Ultimately, she explained, her hope was to use these insights “to usher in true personal healthcare”.
New York Magazine
Kara Swisher is Editor-at-Large at New York Magazine and host of the podcasts On with Kara Swisher and Pivot. Previously she was a contributing New York Times opinion writer and co-founded the technology website Recode. Photo Credit: Phillip Montgomery / New York Magazine
Anne Wocicki is a pioneer in direct-to-consumer DNA testing. She co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal: help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process.